Lindsay A. Rosenwald MD - 10 Jun 2021 Form 4 Insider Report for Checkpoint Therapeutics, Inc. (CKPT)

Role
Director
Signature
/s/ James F. Oliviero, Attorney-in-Fact
Issuer symbol
CKPT
Transactions as of
10 Jun 2021
Net transactions value
$0
Form type
4
Filing time
11 Jun 2021, 20:00:15 UTC
Previous filing
29 Apr 2022
Next filing
08 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CKPT COMMON STOCK Award $0 +16,502 +6.3% $0.000000 278,782 10 Jun 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The 16,502 shares of restricted Common Stock will vest on June 10, 2024, subject to Dr. Rosenwald's continued service on the board on such date.
F2 Includes restricted shares of Common Stock which vest over various time periods, subject to Dr. Rosenwald's continued service on the board.